Arcadia Discloses 5.08% Passive Stake in Above Food Ingredients (2.74M Shares)

Rhea-AI Filing Summary

Arcadia Biosciences reports a passive >5% stake in Above Food Ingredients. Arcadia beneficially owns 2,738,574 shares, representing 5.08% of Above Food Ingredients' common stock based on 51,191,848 shares outstanding as reported by the issuer. Arcadia states it has sole voting and sole dispositive power over those shares and certifies the holdings were not acquired to change or influence control of the issuer. The filing identifies Arcadia as a Delaware corporation and lists the security as common stock (CUSIP 00373V100).

Positive

• Disclosure of a material stake: Arcadia publicly reports ownership above 5%, increasing transparency for investors
• Sole voting and dispositive power: Clear authority over the reported shares simplifies assessment of who controls voting of the position
• Certification of passive intent: The filer states the shares were not acquired to influence control, indicating a non-activist posture

Negative

• None.

Insights

Financial Analyst

TL;DR: Arcadia's 5.08% stake is material but disclosed as passive, so limited immediate governance impact.

Arcadia's holding of 2,738,574 shares crossing the 5% threshold triggers public disclosure and could attract investor attention. Because the filing is a Schedule 13G with a certification that the position is not intended to influence control, this suggests a passive investment rather than an activist intent. For investors, the position size is meaningful relative to outstanding shares but does not, by itself, imply imminent strategic or governance action.

Corporate Governance Expert

TL;DR: Sole voting power is notable; however, the filer affirms no intent to change control, indicating a non-activist stance.

Having sole voting and dispositive power over a 5.08% stake gives Arcadia the formal ability to vote its position on corporate matters, but the Schedule 13G certification signals passive ownership. This distinction matters for monitoring shareholder dynamics: while the stake is large enough to influence close votes if aligned with others, the filing provides no indication of coordination or plans to seek board representation.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Above Food Ingredients Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

00373V100

(CUSIP Number)

08/12/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 00373V100

1

Names of Reporting Persons

Arcadia Biosciences, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,738,574.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 2,738,574.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,738,574.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.08 %

12

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Above Food Ingredients Inc.
(b)	Address of issuer's principal executive offices: 2305 Victoria Avenue, Suite 001 Regina, Saskatchewan S4P 0S7 Canada
Item 2.
(a)	Name of person filing: Arcadia Biosciences, Inc., a Delaware corporation ("Arcadia")
(b)	Address or principal business office or, if none, residence: 5950 Sherry Lane, Suite 215, Dallas, TX 75225
(c)	Citizenship: Delaware
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 00373V100
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 2,738,574 shares of common stock
(b)	Percent of class: 5.08%. The percent of class is based on the sum of (i) 51,191,848 shares of common stock outstanding as of May 2, 2025, as reported by Issuer on its Form 6-K filed with the Securities and Exchange Commission on May 23, 2025, plus (ii) the 2,738,574 shares of common stock owned by Arcadia.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 2,738,574
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 2,738,574
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Arcadia Biosciences, Inc.

Signature:	Thomas J. Schaefer
Name/Title:	Thomas J. Schaefer, CEO
Date:	08/19/2025

FAQ

How many shares of Above Food Ingredients (ABVEW) does Arcadia Biosciences own?

Arcadia owns 2,738,574 shares of common stock.

What percentage of ABVEW does Arcadia's stake represent?

The stake represents 5.08% of the common stock, based on 51,191,848 shares outstanding as reported by the issuer.

Does Arcadia have voting control over its ABVEW shares?

Yes. Arcadia reports sole voting power and sole dispositive power for the 2,738,574 shares.

Is Arcadia acting as an activist investor in ABVEW according to the filing?

No. The filing includes a certification that the securities were not acquired to change or influence control of the issuer, indicating passive intent.

What document reports this ownership and what security is referenced?

The ownership is reported on a Schedule 13G for the issuer's common stock (CUSIP 00373V100).